Pharmacokinetics in experimental and clinical chemotherapy

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Oncogene·2020

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

Blood cancer journal·2017

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Psychological medicine·2016

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Oncogene·2013

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

British journal of cancer·2013

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

Clinical pharmacology and therapeutics·2013

A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.

Cancer chemotherapy and pharmacology·2026

Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.

Cancer chemotherapy and pharmacology·2026

Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.

Cancer chemotherapy and pharmacology·2026

Pharmacological inhibition of store-operated calcium entry enhances sorafenib-induced antitumor effects in Huh7 hepatocellular carcinoma cells.

Cancer chemotherapy and pharmacology·2026

Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database.

Cancer chemotherapy and pharmacology·2026

Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review.

Cancer chemotherapy and pharmacology·2026

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Cureus·2026

Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application.

Gastro hep advances·2026

BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice.

Reproductive biomedicine online·2026

Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol.

PloS one·2026

Inflammatory kinase TBK1 suppresses homologous recombination DNA repair to sensitize tumors to chemotherapy.

Proceedings of the National Academy of Sciences of the United States of America·2026

Haloperidol-Ondansetron versus Dexamethasone-Ondansetron for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Randomized Double-Blind Non-Inferiority Trial.

Journal of perianesthesia nursing : official journal of the American Society of PeriAnesthesia Nurses·2026

Related Experiment Videos

Pharmacokinetics in experimental and clinical chemotherapy

Related Concept Videos

Correction: A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D.

Overexpression of EZH2 in multiple myeloma is associated with poor prognosis and dysregulation of cell cycle control.

A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins.

Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI.

Personalized cancer medicine: molecular diagnostics, predictive biomarkers, and drug resistance.

A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.

Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.

Physiologically based pharmacokinetic modeling to predict human pharmacokinetics of a novel mithramycin analog for Ewing sarcoma.

Pharmacological inhibition of store-operated calcium entry enhances sorafenib-induced antitumor effects in Huh7 hepatocellular carcinoma cells.

Adverse events of cetuximab sarotalocan in photoimmunotherapy: insights from the Japanese adverse drug event report database.

Associations of body composition with neoadjuvant chemotherapy response, toxicity, and prognosis in breast cancer: a scoping review.

Lost in Transition: A Case Study of Oral Baclofen Withdrawal Presenting as Severe Pain.

Cell Therapy in Advanced Cirrhosis: From Preclinical Evidence to Clinical Application.

BRCA1 deficiency in oocytes compromises ovulation without exacerbating follicle loss after chemotherapy in mice.

Preclinical evaluation of Ayurveda and Siddha Herbo-mineral formulations in cancer: A scoping review protocol.

Inflammatory kinase TBK1 suppresses homologous recombination DNA repair to sensitize tumors to chemotherapy.

Haloperidol-Ondansetron versus Dexamethasone-Ondansetron for Prevention of Postoperative Nausea and Vomiting after Laparoscopic Gynecological Surgery: A Randomized Double-Blind Non-Inferiority Trial.

Related Experiment Videos

Pharmacokinetics in experimental and clinical chemotherapy

Related Concept Videos

Related Articles